Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on April 18, 2025

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Motley Fool

8 hours ago

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

MT Newswires

a day ago

BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $557 From $545

MT Newswires

3 days ago

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $617 From $615, Maintains Buy Rating

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

Motley Fool

3 days ago

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

April 2025's Stocks That May Be Priced Below Their Estimated Value

Simply Wall St.

4 days ago

April 2025's Stocks That May Be Priced Below Their Estimated Value

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

4 days ago

Exploring 3 High Growth Tech Stocks In The US Market

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Motley Fool

6 days ago

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Business Wire

7 days ago

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

7 days ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Zacks

8 days ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise

Insider Monkey

8 days ago

Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Motley Fool

8 days ago

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Motley Fool

9 days ago

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

MT Newswires

9 days ago

Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $462 From $459, Keeps Equalweight Rating

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

9 days ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued

Simply Wall St.

9 days ago

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued

Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

Insider Monkey

10 days ago

Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?

Insider Monkey

10 days ago

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?

2 Stocks to Buy if You're Worried About a Recession

Motley Fool

11 days ago

2 Stocks to Buy if You're Worried About a Recession

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

StockStory

11 days ago

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm

Motley Fool

12 days ago

Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm

Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.

Motley Fool

14 days ago

Corporate CFOs Think a Recession Is Coming. Here Are 3 Stocks to Own If They're Right.

Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know

Zacks

15 days ago

Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

StockStory

15 days ago

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?

Insider Monkey

17 days ago

Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

17 days ago

Biotech stocks slide as Marks resignation seen being negative for sector

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

Zacks

17 days ago

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

MT Newswires

17 days ago

RBC Adjusts Price Target on Vertex Pharmaceuticals to $420 From $408, Maintains Sector Perform Rating

These biotech names aren't facing 'huge concern' from tariffs

Yahoo Finance Video

17 days ago

These biotech names aren't facing 'huge concern' from tariffs

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks

18 days ago

Intellia Focuses on Pipeline Development Amid Stiff Competition

Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”

Insider Monkey

18 days ago

Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”

Vertex halts development of diabetes cell therapy after trial failure

Pharmaceutical Technology

18 days ago

Vertex halts development of diabetes cell therapy after trial failure

MT Newswires

18 days ago

Vertex Pharmaceuticals Ends VX-264 Study in Diabetes After Failing to Meet Efficacy Endpoint

Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price

Simply Wall St.

20 days ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price

Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey

21 days ago

Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?

Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know

Zacks

21 days ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should Know

Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Business Wire

21 days ago

Vertex Announces Program Updates for Type 1 Diabetes Portfolio

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

Motley Fool

21 days ago

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Zacks

22 days ago

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Barrons.com

22 days ago

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Zacks

23 days ago

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

MT Newswires

25 days ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $512 From $500, Keeps Overweight Rating

Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”

Insider Monkey

a month ago

Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”

2 Beaten-Down Stocks to Buy on the Dip

Motley Fool

a month ago

2 Beaten-Down Stocks to Buy on the Dip

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Investor's Business Daily

a month ago

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

StockStory

a month ago

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Vertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should Know

Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?

Insider Monkey

a month ago

Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Motley Fool

a month ago

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Insider Monkey

a month ago

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

StockStory

a month ago

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey

a month ago

Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires

Is Vertex Pharmaceuticals (VRTX) Among the Best High Growth Stocks?

Insider Monkey

a month ago

Is Vertex Pharmaceuticals (VRTX) Among the Best High Growth Stocks?

Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?

Zacks

a month ago

Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Motley Fool

a month ago

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?

Zacks

a month ago

Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?

3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Motley Fool

a month ago

3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

Zacks

a month ago

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

GILD vs. VRTX: Which Stock Is the Better Value Option?

Zacks

a month ago

GILD vs. VRTX: Which Stock Is the Better Value Option?

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Sold Shares Worth $1,620,968, According to a Recent SEC Filing

MT Newswires

a month ago

Vertex Pharmaceuticals Insider Sold Shares Worth $1,649,000, According to a Recent SEC Filing

Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds

Insider Monkey

a month ago

Why Vertex Pharmaceuticals Incorporated (VRTX) is the Best Pharma Stock to Buy According to Hedge Funds

Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?

Zacks

a month ago

Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?

Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?

Insider Monkey

a month ago

Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?

Company News for Mar 11, 2025

Zacks

a month ago

Company News for Mar 11, 2025

Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever

Motley Fool

a month ago

Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever

3 Reasons to Avoid VRTX and 1 Stock to Buy Instead

StockStory

a month ago

3 Reasons to Avoid VRTX and 1 Stock to Buy Instead

Where Will Vertex Pharmaceuticals Be in 10 Years?

Motley Fool

a month ago

Where Will Vertex Pharmaceuticals Be in 10 Years?

If I Could Buy Only 1 Growth Stock, This Would Be It

Motley Fool

a month ago

If I Could Buy Only 1 Growth Stock, This Would Be It

3 Magnificent Growth Stocks to Buy in March

Motley Fool

a month ago

3 Magnificent Growth Stocks to Buy in March

Vertex Pharmaceuticals (NasdaqGS:VRTX) Gains UK Approval For New Cystic Fibrosis Treatment

Simply Wall St.

a month ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Gains UK Approval For New Cystic Fibrosis Treatment

MT Newswires

a month ago

Update: Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary

MT Newswires

a month ago

Vertex Pharmaceuticals Gets UK Regulatory Approval for Alyftrek to Treat Cystic Fibrosis

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire

a month ago

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

MT Newswires

a month ago

Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary

Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value

Simply Wall St.

a month ago

Vertex Pharmaceuticals Leads 3 Value Stocks Offering Estimated Intrinsic Value

5 Top Stocks to Buy in March

Motley Fool

a month ago

5 Top Stocks to Buy in March

MT Newswires

2 months ago

Vertex Pharmaceuticals Insider Sold Shares Worth $251,930, According to a Recent SEC Filing

MT Newswires

2 months ago

Vertex Pharmaceuticals Insider Sold Shares Worth $1,259,651, According to a Recent SEC Filing

MT Newswires

2 months ago

Vertex Pharmaceuticals Insider Sold Shares Worth $610,560, According to a Recent SEC Filing

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Business Wire

2 months ago

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Argus Research

2 months ago

Analyst Report: Vertex Pharmaceuticals, Inc.

Argus Research

2 months ago

Market Digest: ICE, NOC, VRTX, UL, ZM

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

Pharmaceutical Technology

2 months ago

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment

GuruFocus.com

2 months ago

Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment

High Growth Tech Stocks To Watch In February 2025

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In February 2025

Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s Top Stock Picks

Insider Monkey

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio’s Top Stock Picks

3 Magnificent Growth Stocks to Buy Right Now

Motley Fool

2 months ago

3 Magnificent Growth Stocks to Buy Right Now

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

Motley Fool

2 months ago

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

GILD or VRTX: Which Is the Better Value Stock Right Now?

Zacks

2 months ago

GILD or VRTX: Which Is the Better Value Stock Right Now?

MT Newswires

2 months ago

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $408 From $407, Maintains Sector Perform Rating

Vertex to Participate in Upcoming March Investor Conferences

Business Wire

2 months ago

Vertex to Participate in Upcoming March Investor Conferences

3 Stocks That Could Trounce the Market in 2025

Motley Fool

2 months ago

3 Stocks That Could Trounce the Market in 2025

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

Motley Fool

2 months ago

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus.com

2 months ago

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Share on Social Networks: